ACHC

In the past six months, Acadia Healthcare Co., Inc. (ACHC) stock surged 100% year-to-date as of September 22, 2026, rebounding sharply from a 2025 slump caused by rising patient-related litigation costs and broader legal and liability concerns. Key events impacting the stock price include the return of former CEO Debra Osteen, an improved financial outlook with management raising its 2026 adjusted EBITDA and earnings outlook after both first and second-quarter results, and increased operating cash flow guidance to $350-$400 million from $285-$325 million while lowering expected capital expenditures to $235-$255 million from $255-$280 million after the second quarter. Additionally, the company expanded its capacity by adding 240 licensed beds through two newly opened joint-venture facilities and opened two new Comprehensive Treatment Center locations in the second quarter of 2026. The stock has risen by 4.51% in the past week, 7.47% in the past month, and 33.56% over the last year.